Study on Tirzepatide Weight Loss MechanismTirzepatideA new study in Cell Metabolism reveals how Tirzepatide, the most effective FDA-approved weight loss drug, works by increasing fat oxidation and reducing appetite without impacting metabolic adaptation in obese individuals.
2024 Global Top 10 Pharmaceutical CompaniesMarket TrendThe 2024 global ranking of the top 10 pharmaceutical companies showcases the continued strength of industry leaders like Johnson & Johnson, Roche, and Merck. Pfizer, AstraZeneca, and Eli Lilly also maintain strong positions with impressive growth and strategic investments.
Top 10 Pharmaceutical Giants' R&D Investments in 2024Market TrendIn 2024, pharmaceutical giants face a quiet battle over innovation and efficiency. From Merck’s 41% R&D drop to AbbVie’s bold growth, their strategies and investments reveal shifting power in the industry. A glimpse into the future of drug development.
Top 10 Global Pharmaceutical Giants in Autoimmune Business in 2024AutoimmuneThe autoimmune sector saw explosive growth in 2024, with mergers and acquisitions skyrocketing by 150%. Giants like AbbVie, J&J, and Eli Lilly are reshaping the landscape. Explore the Top 10 revenue rankings in the autoimmune business and future trends.
Big Pharma -Waiting for the other Shoe to DropBiotechExplore the shifting landscape of big pharma as clinical trial results, patent cliffs, and innovative therapies shape 2025. Discover how giants like Eli Lilly, Pfizer, and Novo Nordisk navigate challenges and opportunities in weight loss, oncology, and vaccines.
Top 10 Diabetes Medications to Watch in 2024DiabetesDiscover the top 10 diabetes medications of 2024, including Ozempic, Jardiance, and Mounjaro. Learn about their sales, innovations, and why they're leading in the treatment of diabetes and related conditions.
Eli Lilly Q3 2024 Financial statementsFinancial statementsEli Lilly's Q3 2024 report reveals strong growth with $31.5 billion in revenue, driven by $11 billion in sales from tirzepatide products Mounjaro and Zepbound, Mounjaro's sales doubled. With an expanded production capacity, Eli Lilly projecting a market potential of $150 billion by 2030.
MNC Profiles: Who Values ??the Chinese Market Most?AstraZenecaExplore the competitive landscape of multinational pharmaceutical companies (MNCs) in China’s booming healthcare market. Delves into MNC revenue trends, strategies, and insights, highlighting which companies value the Chinese market most.
EN
Agricultural News
Food News
Industrial News
Cosmetic News
Pharmaceutical News
Science News
